erythrosine has been researched along with Epilepsy in 16 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To analyze cellular mechanisms of limbic-seizure suppression, the response to pilocarpine-induced seizures was investigated in cortex and thalamus, comparing epilepsy-resistant rats Proechimys guyannensis with Wistar rats." | 7.75 | Different patterns of neuronal activation and neurodegeneration in the thalamus and cortex of epilepsy-resistant Proechimys rats versus Wistar rats after pilocarpine-induced protracted seizures. ( Andrioli, A; Bentivoglio, M; Cavalheiro, EA; Fabene, PF; Spreafico, R, 2009) |
| "Evidence for increased calpain activity has been described in the hippocampus of rodent models of temporal lobe epilepsy." | 7.74 | Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus. ( Araújo, IM; Bahr, BA; Brundin, P; Carreira, BP; Carvalho, CM; Gil, JM; Mohapel, P; Petersen, A; Pinheiro, PS; Soulet, D, 2008) |
| "Epilepsy is a serious neurological disorder in human beings and the long-term pathological events remain largely obscure." | 5.35 | Time-course of neuronal death in the mouse pilocarpine model of chronic epilepsy using Fluoro-Jade C staining. ( Chen, LW; Huang, YG; Liu, YH; Wang, L, 2008) |
| "To analyze cellular mechanisms of limbic-seizure suppression, the response to pilocarpine-induced seizures was investigated in cortex and thalamus, comparing epilepsy-resistant rats Proechimys guyannensis with Wistar rats." | 3.75 | Different patterns of neuronal activation and neurodegeneration in the thalamus and cortex of epilepsy-resistant Proechimys rats versus Wistar rats after pilocarpine-induced protracted seizures. ( Andrioli, A; Bentivoglio, M; Cavalheiro, EA; Fabene, PF; Spreafico, R, 2009) |
| "Evidence for increased calpain activity has been described in the hippocampus of rodent models of temporal lobe epilepsy." | 3.74 | Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus. ( Araújo, IM; Bahr, BA; Brundin, P; Carreira, BP; Carvalho, CM; Gil, JM; Mohapel, P; Petersen, A; Pinheiro, PS; Soulet, D, 2008) |
| "Epilepsy is a common and refractory neurological disorder, but the neuronal regulatory mechanisms of epileptogenesis remain largely unclear." | 1.37 | Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons. ( Hu, XL; Liu, YY; Mei, L; Tan, GH; Xiong, ZQ; Yin, DM, 2011) |
| "The development of epilepsy is often associated with marked changes in central nervous system cell structure and function." | 1.36 | Proteomic profiling of the epileptic dentate gyrus. ( Cao, R; Cho, HY; Choi, YS; Dziema, H; Jung, YJ; Li, A; Obrietan, K, 2010) |
| "Epilepsy is a serious neurological disorder in human beings and the long-term pathological events remain largely obscure." | 1.35 | Time-course of neuronal death in the mouse pilocarpine model of chronic epilepsy using Fluoro-Jade C staining. ( Chen, LW; Huang, YG; Liu, YH; Wang, L, 2008) |
| " The inhibitory potency of the tested drugs from the dose-response relationships was cyclosporin A>verapamil> phenytoin> carbamazepine> lamotrigine>phenobarbital>valproic acid, levetiracetam, gabapentin." | 1.35 | Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs. ( Chen, CC; Hung, CC; Lin, CJ; Liou, HH, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordon, RY | 1 |
| Shubina, LV | 1 |
| Kapralova, MV | 1 |
| Pershina, EB | 1 |
| Khutzian, SS | 1 |
| Arhipov, VI | 1 |
| Wang, L | 1 |
| Liu, YH | 1 |
| Huang, YG | 1 |
| Chen, LW | 1 |
| Andrioli, A | 1 |
| Fabene, PF | 1 |
| Spreafico, R | 1 |
| Cavalheiro, EA | 1 |
| Bentivoglio, M | 1 |
| Fritsch, B | 1 |
| Qashu, F | 1 |
| Figueiredo, TH | 1 |
| Aroniadou-Anderjaska, V | 1 |
| Rogawski, MA | 1 |
| Braga, MF | 1 |
| Luna-Tortós, C | 1 |
| Fedrowitz, M | 1 |
| Löscher, W | 1 |
| Li, A | 1 |
| Choi, YS | 1 |
| Dziema, H | 1 |
| Cao, R | 1 |
| Cho, HY | 1 |
| Jung, YJ | 1 |
| Obrietan, K | 1 |
| Kovács, R | 1 |
| Raue, C | 1 |
| Gabriel, S | 1 |
| Heinemann, U | 1 |
| Tan, GH | 1 |
| Liu, YY | 1 |
| Hu, XL | 1 |
| Yin, DM | 1 |
| Mei, L | 1 |
| Xiong, ZQ | 1 |
| Kharlamov, EA | 1 |
| Kharlamov, A | 1 |
| Kelly, KM | 1 |
| Yan, HD | 1 |
| Ishihara, K | 1 |
| Hanaya, R | 1 |
| Kurisu, K | 1 |
| Serikawa, T | 1 |
| Sasa, M | 1 |
| Araújo, IM | 1 |
| Gil, JM | 1 |
| Carreira, BP | 1 |
| Mohapel, P | 1 |
| Petersen, A | 1 |
| Pinheiro, PS | 1 |
| Soulet, D | 1 |
| Bahr, BA | 1 |
| Brundin, P | 1 |
| Carvalho, CM | 1 |
| Hung, CC | 1 |
| Chen, CC | 1 |
| Lin, CJ | 1 |
| Liou, HH | 1 |
| Bonnet, U | 1 |
| Bingmann, D | 1 |
| Wiemann, M | 1 |
| Wolf, OT | 1 |
| Dyakin, V | 1 |
| Patel, A | 1 |
| Vadasz, C | 1 |
| de Leon, MJ | 1 |
| McEwen, BS | 1 |
| Bulloch, K | 1 |
| Maheshwari, PK | 1 |
| Gulati, A | 1 |
| Sharma, B | 1 |
| Misra, PK | 1 |
| Malik, GK | 1 |
| Kumar, V | 1 |
| Dhawan, BN | 1 |
| Wallace, JD | 1 |
| Weintraub, MI | 1 |
| Mattson, RH | 1 |
| Rosnagle, R | 1 |
16 other studies available for erythrosine and Epilepsy
| Article | Year |
|---|---|
[Peculiarities of neurodegeneration in hippocampus fields after kainic acid action in rats].
Topics: Animals; Apoptosis; Benzoxazines; Cerebral Ventricles; Epilepsy; Fluoresceins; GluK2 Kainate Recepto | 2014 |
Time-course of neuronal death in the mouse pilocarpine model of chronic epilepsy using Fluoro-Jade C staining.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Brain; Cerebral Cortex; Chronic Disease; Convulsa | 2008 |
Different patterns of neuronal activation and neurodegeneration in the thalamus and cortex of epilepsy-resistant Proechimys rats versus Wistar rats after pilocarpine-induced protracted seizures.
Topics: Analysis of Variance; Animals; Cell Count; Cerebral Cortex; Disease Models, Animal; Electroencephalo | 2009 |
Pathological alterations in GABAergic interneurons and reduced tonic inhibition in the basolateral amygdala during epileptogenesis.
Topics: Amygdala; Animals; Convulsants; Down-Regulation; Epilepsy; Fluoresceins; gamma-Aminobutyric Acid; Gl | 2009 |
Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy.
Topics: Anticonvulsants; Biological Transport; Cell Line; Central Nervous System Agents; Epilepsy; Fluoresce | 2010 |
Proteomic profiling of the epileptic dentate gyrus.
Topics: Actins; Animals; Dentate Gyrus; Disease Models, Animal; Electroencephalography; Electrophoresis, Gel | 2010 |
Functional test of multidrug transporter activity in hippocampal-neocortical brain slices from epileptic patients.
Topics: Adjuvants, Pharmaceutic; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; E | 2011 |
Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons.
Topics: Analysis of Variance; Animals; Anticonvulsants; Calcium-Calmodulin-Dependent Protein Kinase Type 2; | 2011 |
Changes in neuropeptide Y protein expression following photothrombotic brain infarction and epileptogenesis.
Topics: Animals; Astrocytes; Brain; Brain Infarction; Dentate Gyrus; Disease Models, Animal; DNA-Binding Pro | 2007 |
Voltage-dependent calcium channel abnormalities in hippocampal CA3 neurons of spontaneously epileptic rats.
Topics: Action Potentials; Animals; Calcium; Calcium Channels; Epilepsy; Fluoresceins; Hippocampus; Membrane | 2007 |
Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus.
Topics: Animals; Calpain; Caspases; Convulsants; Dipeptides; Disease Models, Animal; Enzyme Activation; Enzy | 2008 |
Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs.
Topics: Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Su | 2008 |
Intracellular pH modulates spontaneous and epileptiform bioelectric activity of hippocampal CA3-neurones.
Topics: Animals; Epilepsy; Fluoresceins; Guanidines; Guinea Pigs; Hippocampus; Hydrogen-Ion Concentration; I | 2000 |
Volumetric structural magnetic resonance imaging (MRI) of the rat hippocampus following kainic acid (KA) treatment.
Topics: Animals; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Astrocytes; Avian Proteins; Basigin; B | 2002 |
Blood-brain barrier in non-infective convulsive disorders.
Topics: Blood-Brain Barrier; Carbohydrates; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Child; Child, | 1985 |
Status epilepticus as a complication of intrathecal fluorescein. Case report.
Topics: Aged; Cerebrospinal Fluid Rhinorrhea; Contrast Media; Epilepsy; Fluoresceins; Glucocorticoids; Human | 1972 |